跳至主要内容
临床试验/NCT03337789
NCT03337789已完成不适用

Efficacy of Polygonatum Sibiricum on Sleep Quality Improvement

Ewha Womans University2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年11月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Chagne from baseline physical activity at 4 weeks assessed by actigraph

研究概览

简要总结

This study aims to investigate the efficacy and safety of Polygonatum sibiricum for sleep quality improvement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female volunteers who are between the ages of 20 and 65
  • Experienced any of the following sleep problems, at least more than once a week for more than 2 months: 1) difficulty in falling asleep or staying asleep; 2) waking up at dusk and not being able to fall asleep again; 3) not feeling refreshed even after getting some sleep.

排除标准

  • Diagnosed with insomnia assessed with a structured interview and sleep scale measurements
  • Possibility of drug-induced sleep disorders due to current intake of medication (i.e., corticosteroid, statin, etc)
  • Had taken sleeping pills (i.e., zolpidem, benzodiazepine) during the past 2 months
  • Diagnosed with any major medical or neurological disorders assessed during medical history taking, physical examination or experimental tests.
  • Diagnosed with any axis 1 psychiatric disorders (depressive disorder, bipolar disorder, alcohol dependence, schizophrenia) evaluated with a structured instrument
  • A history of traumatic brain injury with loss of consciousness, or any contraindications to MRI (i.e., claustrophobia, metallic foreign devices in body)
  • Had taken psychotropic drugs within the past 3 months before study participation
  • Allergic to polygonatum sibiricum or experienced side effects after consumption of any product containing polygonatum sibiricum
  • Participated in another clinical trial or took other medications during the period that may influence the results of this clinical trial
  • Currently taking contraceptive pills
  • Planning for pregnancy during the period of study participation, currently pregnant or breastfeeding

研究组 & 干预措施

Polygonatum sibiricum

Experimental

干预措施: Polygonatum sibiricum (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Chagne from baseline physical activity at 4 weeks assessed by actigraph

时间窗: Baseline and week 4

Change from baseline objective sleep quality at 4 weeks assessed by polysomnography

时间窗: Baseline and week 4

Change from baseline subjective sleep quality at 4 weeks assessed by Pittsburgh Sleep Quality Index

时间窗: Baseline and week 4

次要结局

  • Change from baseline cognitive functions at 4 weeks assessed by the neuropsychological test battery(Baseline and week 4)
  • Change from baseline depressive symptom levels at 4 weeks assessed by the Hamilton Depression Rating Scale(Baseline and week 4)
  • Change from baseline brain structure, function, and metabolism at 4 weeks assessed by computational analysis of magnetic resonance imaging data(Baseline and week 4)
  • Change from baseline anxiety symptom levels at 4 weeks assessed by the Hamilton Anxiety Rating Scale(Baseline and week 4)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jieun Kim

Professor

Ewha Womans University

研究点 (2)

Loading locations...

相似试验

Efficacy of Polygonatum Sibiricum on Sleep Quality... | 临床试验